Results 151 to 160 of about 9,484 (203)

Effect of Topical Travoprost 0.004% Drops on Central Corneal Thickness in Patients With Primary Open-Angle Glaucoma. [PDF]

Cureus
Mukhtar M, Zafar F, Luqman F, Bibi H, Sarfaraz H.   +4 more
europepmc   +1 more source

Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies. [PDF]

Front Pharmacol
Torres de Souza G, Williams G, Vicente Silva CC, Chiovatto CB, Epstein GK, Vila-Vecilla L, Russo V.   +6 more
europepmc   +1 more source

Five-Year Outcomes of Omidenepag Isopropyl Monotherapy for Untreated Primary Open-Angle Glaucoma. [PDF]

Cureus
Kanamori A, Kanamori N.
europepmc   +1 more source

Periorbital skin hypopigmentation associated with the use of topical glaucoma medications. [PDF]

Digit J Ophthalmol
Karimaghaei S, Yee J, Elhusseiny AM.
europepmc   +1 more source

Benefit of omidenepag isopropyl ophthalmic solution in treatment persistence in Japanese patients with glaucoma. [PDF]

Sci Rep
Kashiwagi K, Nakano T, Nakazawa T, Fuwa M, Otsuka N, Shii D, Miyahara R.   +6 more
europepmc   +1 more source

A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension. [PDF]

Eye (Lond)
Baudouin C, Stalmans I, Bourne R, Larrosa JM, Schmickler S, Seleznev A, Oddone F, Phase III study group.   +7 more
europepmc   +1 more source

Intractable Elevated Intraocular Pressure during Plaque Brachytherapy for Posterior Choroidal Tumors: A Case Report. [PDF]

Ocul Oncol Pathol
Belmouhand M, Kiilgaard JF, Faber C.
europepmc   +1 more source

Severe nausea and vomiting after teprotumumab initiation with corticosteroid pretreatment: a case report. [PDF]

Int J Ophthalmol
Youn J, Firn K, Hawy E, Van Putten D.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Latanoprost

Reactions Weekly, 2012
Tim Ibbotson
exaly   +6 more sources